Which has better earnings and valuation, WAY or DOCS?

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.21B 3.72 $112.09M $0.70 33.40 Doximity $644.86M 6.12 $196.05M $0.99 21.81

Is WAY or DOCS more profitable?

Doximity has a net margin of 30.40% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 20.40% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Doximity 30.40% 20.40% 17.43%

Does the media prefer WAY or DOCS?

In the previous week, Doximity had 4 more articles in the media than Waystar. MarketBeat recorded 11 mentions for Doximity and 7 mentions for Waystar. Doximity's average media sentiment score of 1.10 beat Waystar's score of 0.79 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, DOCS or HTFL?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 6.12 $196.05M $0.99 21.81 Heartflow $176.03M 13.31 -$116.79M -$3.11 N/A

Is DOCS or HTFL more profitable?

Doximity has a net margin of 30.40% compared to Heartflow's net margin of -58.42%. Doximity's return on equity of 20.40% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 30.40% 20.40% 17.43% Heartflow -58.42% N/A -20.02%

Does the media prefer DOCS or HTFL?

In the previous week, Doximity had 5 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Doximity and 6 mentions for Heartflow. Doximity's average media sentiment score of 1.10 beat Heartflow's score of 0.85 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, DOCS or CERT?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 6.12 $196.05M $0.99 21.81 Certara $421.75M 2.95 -$1.60M -$0.45 N/A

Is DOCS or CERT more profitable?

Doximity has a net margin of 30.40% compared to Certara's net margin of -16.75%. Doximity's return on equity of 20.40% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 30.40% 20.40% 17.43% Certara -16.75% 3.86% 2.65%

Does the media favor DOCS or CERT?

In the previous week, Certara had 8 more articles in the media than Doximity. MarketBeat recorded 19 mentions for Certara and 11 mentions for Doximity. Doximity's average media sentiment score of 1.10 beat Certara's score of 0.36 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 8 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is DOCS or TDOC more profitable?

Doximity has a net margin of 30.40% compared to Teladoc Health's net margin of -7.13%. Doximity's return on equity of 20.40% beat Teladoc Health's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 30.40% 20.40% 17.43% Teladoc Health -7.13% -12.15% -5.83%

Does the media favor DOCS or TDOC?

In the previous week, Teladoc Health had 20 more articles in the media than Doximity. MarketBeat recorded 31 mentions for Teladoc Health and 11 mentions for Doximity. Doximity's average media sentiment score of 1.10 beat Teladoc Health's score of 0.14 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 8 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 8 Negative mention(s) 3 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, SDGR or DOCS?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $254.91M 4.75 -$103.26M -$1.41 N/A Doximity $644.86M 6.12 $196.05M $0.99 21.81

Is SDGR or DOCS more profitable?

Doximity has a net margin of 30.40% compared to Schrodinger's net margin of -40.61%. Doximity's return on equity of 20.40% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -40.61% -30.85% -15.32% Doximity 30.40% 20.40% 17.43%

Does the media prefer SDGR or DOCS?

In the previous week, Schrodinger and Schrodinger both had 11 articles in the media. Doximity's average media sentiment score of 1.10 beat Schrodinger's score of 0.77 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Doximity (DOCS) Competitors

$21.60 -0.29 (-1.34%)

Closing price 08/5/2026 03:59 PM Eastern

Extended Trading

$21.66 +0.06 (+0.30%)

As of 08:13 AM Eastern

Compare

DOCS vs. WAY, HTFL, CERT, TDOC, and SDGR

Should you buy Doximity stock or one of its competitors? MarketBeat compares Doximity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Doximity include Waystar (WAY), Heartflow (HTFL), Certara (CERT), Teladoc Health (TDOC), and Schrodinger (SDGR). These companies are all part of the "healthcare technology" industry.

How does Doximity compare to Waystar?

Waystar (NASDAQ:WAY) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Waystar has a beta of 0.06, suggesting that its stock price is 94% less volatile than the broader market. Comparatively, Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.21B	3.72	$112.09M	$0.70	33.40
Doximity	$644.86M	6.12	$196.05M	$0.99	21.81

87.2% of Doximity shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Doximity had 4 more articles in the media than Waystar. MarketBeat recorded 11 mentions for Doximity and 7 mentions for Waystar. Doximity's average media sentiment score of 1.10 beat Waystar's score of 0.79 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has a net margin of 30.40% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 20.40% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Doximity	30.40%	20.40%	17.43%

Waystar presently has a consensus price target of $35.14, suggesting a potential upside of 50.28%. Doximity has a consensus price target of $29.33, suggesting a potential upside of 35.83%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1 Sell rating(s)	2 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.96
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29

Summary

Doximity beats Waystar on 11 of the 17 factors compared between the two stocks.

How does Doximity compare to Heartflow?

Doximity (NYSE:DOCS) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Doximity has a net margin of 30.40% compared to Heartflow's net margin of -58.42%. Doximity's return on equity of 20.40% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	30.40%	20.40%	17.43%
Heartflow	-58.42%	N/A	-20.02%

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	6.12	$196.05M	$0.99	21.81
Heartflow	$176.03M	13.31	-$116.79M	-$3.11	N/A

Doximity currently has a consensus target price of $29.33, indicating a potential upside of 35.83%. Heartflow has a consensus target price of $36.57, indicating a potential upside of 34.60%. Given Doximity's higher probable upside, equities research analysts plainly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Doximity had 5 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Doximity and 6 mentions for Heartflow. Doximity's average media sentiment score of 1.10 beat Heartflow's score of 0.85 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Heartflow on 13 of the 16 factors compared between the two stocks.

How does Doximity compare to Certara?

Doximity (NYSE:DOCS) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, Certara had 8 more articles in the media than Doximity. MarketBeat recorded 19 mentions for Certara and 11 mentions for Doximity. Doximity's average media sentiment score of 1.10 beat Certara's score of 0.36 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	8 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.2% of Doximity shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 31.8% of Doximity shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Doximity presently has a consensus price target of $29.33, suggesting a potential upside of 35.83%. Certara has a consensus price target of $8.95, suggesting a potential upside of 11.74%. Given Doximity's higher possible upside, equities research analysts clearly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29
Certara	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.46

Doximity has a net margin of 30.40% compared to Certara's net margin of -16.75%. Doximity's return on equity of 20.40% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	30.40%	20.40%	17.43%
Certara	-16.75%	3.86%	2.65%

Doximity has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Certara has a beta of 1.44, suggesting that its share price is 44% more volatile than the broader market.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	6.12	$196.05M	$0.99	21.81
Certara	$421.75M	2.95	-$1.60M	-$0.45	N/A

Summary

Doximity beats Certara on 14 of the 17 factors compared between the two stocks.

How does Doximity compare to Teladoc Health?

Doximity (NYSE:DOCS) and Teladoc Health (NYSE:TDOC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

87.2% of Doximity shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 31.8% of Doximity shares are owned by company insiders. Comparatively, 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Doximity currently has a consensus target price of $29.33, suggesting a potential upside of 35.83%. Teladoc Health has a consensus target price of $7.54, suggesting a potential upside of 8.99%. Given Doximity's stronger consensus rating and higher probable upside, equities research analysts plainly believe Doximity is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Teladoc Health had 20 more articles in the media than Doximity. MarketBeat recorded 31 mentions for Teladoc Health and 11 mentions for Doximity. Doximity's average media sentiment score of 1.10 beat Teladoc Health's score of 0.14 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	8 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	8 Negative mention(s)	3 Very Negative mention(s)	Neutral

Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market.

Doximity has a net margin of 30.40% compared to Teladoc Health's net margin of -7.13%. Doximity's return on equity of 20.40% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	30.40%	20.40%	17.43%
Teladoc Health	-7.13%	-12.15%	-5.83%

Doximity has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	6.12	$196.05M	$0.99	21.81
Teladoc Health	$2.49B	0.50	-$200.32M	-$0.99	N/A

Summary

Doximity beats Teladoc Health on 14 of the 17 factors compared between the two stocks.

How does Doximity compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

Schrodinger has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

Schrodinger currently has a consensus price target of $20.25, indicating a potential upside of 23.48%. Doximity has a consensus price target of $29.33, indicating a potential upside of 35.83%. Given Doximity's higher possible upside, analysts plainly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29

Doximity has a net margin of 30.40% compared to Schrodinger's net margin of -40.61%. Doximity's return on equity of 20.40% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-40.61%	-30.85%	-15.32%
Doximity	30.40%	20.40%	17.43%

79.1% of Schrodinger shares are held by institutional investors. Comparatively, 87.2% of Doximity shares are held by institutional investors. 10.1% of Schrodinger shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$254.91M	4.75	-$103.26M	-$1.41	N/A
Doximity	$644.86M	6.12	$196.05M	$0.99	21.81

In the previous week, Schrodinger and Schrodinger both had 11 articles in the media. Doximity's average media sentiment score of 1.10 beat Schrodinger's score of 0.77 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Schrodinger on 14 of the 16 factors compared between the two stocks.

Get Doximity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOCS vs. The Competition

Export

Metric	Doximity	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.00B	$1.42B	$6.86B	$24.08B
Dividend Yield	N/A	4.74%	2.60%	3.70%
P/E Ratio	21.81	275.83	280.40	32.26
Price / Sales	6.12	64.16	562.49	81.25
Price / Cash	17.66	30.98	71.79	32.38
Price / Book	4.16	4.87	12.96	6.92
Net Income	$196.05M	-$25.90M	$3.49B	$1.07B
7 Day Performance	1.64%	4.14%	2.42%	2.10%
1 Month Performance	-5.77%	-1.59%	-2.86%	1.67%
1 Year Performance	N/A	-18.95%	75.30%	19.52%

Doximity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOCS Doximity	4.3298 of 5 stars	$21.60 -1.3%	$29.33 +35.8%	N/A	$4.00B	$644.86M	21.81	890	Positive News Options Volume
WAY Waystar	4.5634 of 5 stars	$21.11 flat	$35.14 +66.4%	-32.9%	$4.05B	$1.21B	30.16	1,700
HTFL Heartflow	3.412 of 5 stars	$25.23 flat	$36.57 +45.0%	N/A	$2.18B	$176.03M	N/A	699
CERT Certara	2.7045 of 5 stars	$8.10 flat	$8.85 +9.3%	-18.8%	$1.26B	$419.75M	N/A	1,576	News Coverage Earnings Report Analyst Forecast
TDOC Teladoc Health	1.8731 of 5 stars	$6.71 +0.0%	$7.50 +11.7%	-0.9%	$1.21B	$2.49B	N/A	5,600	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DOCS) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Doximity (DOCS) Competitors